awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q34593276-1E8CD3CC-34D1-4876-82B2-A4824FC1BF27
Q34593276-1E8CD3CC-34D1-4876-82B2-A4824FC1BF27
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34593276-1E8CD3CC-34D1-4876-82B2-A4824FC1BF27
Patients with acute myeloid leukemia and RAS mutations benefit most from postremission high-dose cytarabine: a Cancer and Leukemia Group B study
P31
Q34593276-1E8CD3CC-34D1-4876-82B2-A4824FC1BF27
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34593276-1E8CD3CC-34D1-4876-82B2-A4824FC1BF27
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
c458e9f645fdfac6babe935b2c1b151db8a6206c
P31
scholarly article